SAMANTHA HUGHES: Open Payments
NPI 1215578364 · YORKTOWN, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$519 in 27 payments from 13 companies in 2025. Trend: 2023 $169 · 2024 $391 · 2025 $519
Food & beverage: $500Education: $19
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 5 | $111 |
| Novo Nordisk Inc | 3 | $71 |
| GlaxoSmithKline, LLC. | 3 | $51 |
| Axsome Therapeutics, Inc. | 3 | $48 |
| PFIZER INC. | 2 | $40 |
| Lilly USA, LLC | 2 | $37 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $36 |
| AstraZeneca Pharmaceuticals LP | 2 | $32 |
| Janssen Pharmaceuticals, Inc | 1 | $24 |
| Gilead Sciences, Inc. | 1 | $22 |
Products named: UBRELVY, Auvelity, QULIPTA, MOUNJARO, JARDIANCE, TRELEGY ELLIPTA, Ozempic, SPRAVATO.
Industry payments across VA — which companies pay providers there.
